Results 251 to 260 of about 214,982 (356)

A new paradigm of islet adaptations in human pregnancy: insights from immunohistochemistry and proteomics. [PDF]

Nat Commun
Seedat F, Holden K, Davis S, Fischer R, Bancroft J, Drydale E, Kandzija N, Todd JA, Vatish M, Stefana MI.   +9 more
europepmc   +1 more source

Erythematous Papules and Plaques in an Infant Receiving Glucagon Therapy

JEADV Clinical Practice, EarlyView.
Sara Al Janahi, Alya Al‐Ali, Meera Al Adawi, Yusra S. Al Ali, Harish Bangalore   +4 more
wiley   +1 more source

A geriatrician's approach to managing the complex older adult with obesity

Obesity, EarlyView.
Abstract The prevalence of obesity in older adults is rapidly increasing due to the demographic shift occurring globally. Older adults with obesity face health care challenges due to multimorbidity, functional dependency, and disability. This population often has prior history of struggles through weight‐loss attempts during the middle years of life ...
Shenbagam Dewar
wiley   +1 more source

GLP‐1 Receptor Agonists for Obstructive Sleep Apnea: An Otolaryngologist's Prescription?

The Laryngoscope, EarlyView.
Alina Zgardau, Ryan Chin Taw Cheong, Kenny Peter Pang, Brian W. Rotenberg   +3 more
wiley   +1 more source

Evolution of multidisciplinary obesity treatments: past, present, and future role of nutrition

Obesity, EarlyView.
Abstract Obesity is a complex chronic disease requiring lifelong comprehensive treatment. In addition to lifestyle counseling that improves nutrition and physical activity, a promising new generation of obesity medications has been added to bariatric procedures as therapeutic options to achieve weight reduction and improve health outcomes.
Steven B. Heymsfield, Philip J. Atherton, Sandra Christensen, Colleen Tewksbury, Amanda Velazquez, Jens Walter, Ellen E. Blaak   +6 more
wiley   +1 more source

The 'Designer' Artificial Pancreas: How Does Current Technology Mimic Pancreatic Physiology? [PDF]

Cureus
Ayliffe Daly L.
europepmc   +1 more source

Association of Glucagon‐Like Peptide‐1 Receptor Agonists With Cancer Risk in Older Adults With Type 2 Diabetes

Obesity, EarlyView.
ABSTRACT Objective The real‐world evidence on the association between glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and cancer risk remains limited and mixed. Methods In 2013–2020 national Medicare claims data, we included cancer‐naïve patients with type 2 diabetes (T2D). We identified those who initiated GLP‐1 RA, sodium‐glucose cotransporter 2
Ying Lu, Hao Dai, Huilin Tang, William T. Donahoo, Thomas J. George, Ramon C. Sun, Sizun Jiang, Aik Choon Tan, Yi Guo, Jonathan D. Licht, John M. Allen, Kelvin P. Lee, Jingchuan Guo, Jiang Bian   +13 more
wiley   +1 more source

Proinflammatory cytokine-induced alpha cell impairment in human islet microtissues is partially restored by dual incretin receptor agonism. [PDF]

Diabetologia
Henriksen K, Rufer C, Title AC, Jawurek S, Hartmann B, Holst JJ, Knop FK, Yesildag B, Størling J.   +8 more
europepmc   +1 more source

The Supportive Effect of Acarbose to Orlistat in Weight Management—A Randomized, Double‐Blind, Multiarm Phase 2 Trial

Obesity, EarlyView.
ABSTRACT Objective This study aimed to evaluate the added effect of acarbose to orlistat on relative weight loss in the novel antiobesity medication EMP16. Methods In this 6‐month double‐blind trial, 240 individuals with obesity or overweight and comorbidities were randomized equally into three groups: (1) EMP16 (120 mg modified release orlistat/40 mg ...
Ulf Holmbäck, Stefan Grudén, Sandra Kuusk, Helena Litorp, Joakim Englund, Arvid Söderhäll, Göran Alderborn, Anders Forslund   +7 more
wiley   +1 more source

Allosteric communication mechanism in the glucagon receptor. [PDF]

J Biol Chem
van der Velden WJC, Mukhaleva E, Vaidehi N.   +2 more
europepmc   +1 more source